tailieunhanh - Clinical pharmacy and therapeutics

Now in its fifth edition, this best-selling, multidisciplinary textbook continues to draw on the skills of pharmacists and clinicians to present optimal drug regimens. The authors integrate an understanding of the disease processes with an appreciation of pathophysiological processes, clinical pharmacy and the evidence base. | THIRD EDITION Clinical Pharmacy Therapeutics 3 I Edited by ROGER WALKER T CUVE EDWARDS Clinical Pharmacy and Therapeutics EDITED BY Roger Walker BPharm PhD MRPharmS HonMFPHM Professor of Pharmacy Practice Welsh School of Pharmacy Cardiff Director of Pharmaceutical Public Health Gwent Wales UK Clive Edwards BPharm PhD MRPharmS Prescribing Adviser North Tyneside Primary Care Trust Newcastle upon Tyne UK THIRD EDITION CHURCHILL LIVINGSTONE EDINBURGH LONDON NEW YORK OXFORD PHILADELPHIA ST LOUIS SYDNEY TORONTO 2003 Contents Section 1 General Practical pharmacokinetics 3 R Fitzpatrick 2 Drug interactions 21 A Lee I. H. stockley 3 Adverse drug reactions 33 - Lee s. H. L. Thomas - Laboratory data 47 - A. Wynne c. Edwards Parenteral nutrition 67 s J. Dunnett Pharmacoeconomics 91 J Cooke Section 2 Life stages 7 Neonates 101 M p. Ward Platt 3 Paediatrics 111 c Barker A. J. Nunn s. Turner 9 Geriatrics 127 - G. M. Shetty K. Woodhouse Section 3 Therapeutics Gastrointestinal disorders Peptic ulcer disease 143 s Ghosh M. Kinnear Inflammatory bowel disease 163 B K. Evans 2 Constipation and diarrhoea 179 R. Walker Hepatic disorders 3 Adverse effects of drugs on the liver 193 B E. Cadman B. Featherstone - Liver disease 209 z N . Ward M. J. Daly Renal disorders 15. Acute renal failure 229 J. Marriott s. Smith 16. Chronic renal failure 247 J. Marriott s. Smith Cardiovascular disorders 17. Hypertension 265 s. H. L. Thomas 18. Coronary heart disease 279 D. Scott 19. Congestive heart failure 299 s. A. Hudson J. McAnaw F. Reid 20. Cardiac arrhythmias 321 D. Scott 21. Thrombosis 339 p. A. Routledge H. G. M. Shetty 22. Dyslipidaemia 353 R. Walker Respiratory disorders 23. Asthma 375 K. R Gibbs M. Small 24. Chronic obstructive pulmonary disease 397 K. R Gibbs M. Small 25. Drug-induced lung disease 413 N. R Keaney Neurological and psychological disorders 26. Insomnia and anxiety 423 C. H. Ashton 27. Affective disorders 439 R Pratt 28. Schizophrenia 455 D. Branford 29. Epilepsy 465 s. Dhillon .

• Y học thường thức
• chloroguanide bioactivation
• Drug Interactions
• ley points
• epidemiology
• aetiology